SCHEMBL7305629

SCHEMBL7305629

CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)c1ccc(C(=O)OC)cc1)C(=O)CSCc1ccco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
POLB P06746 2/20 0.44
ALDH1A1 P00352 2/20 0.44
USP2 O75604 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TAS1R3 Q7RTX0 5/20 0.39
TAS1R1 Q7RTX1 5/20 0.39
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
CTSB P07858 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7442938 1.00 MAPT (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7300813 0.93 CTSS (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7300831 0.93 CTSS (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7299094 0.92 ALDH1A1 (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7299101 0.92 ALDH1A1 (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7303780 0.91 POLB (0.48) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7303804 0.91 POLB (0.48) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7313599 0.91 CTSL (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL7313606 0.91 CTSL (0.44) MAPTPOLBALDH1A1USP2HSD17B10
SCHEMBL8887842 0.89 NPC1 (0.49) MAPTPOLBALDH1A1USP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5834508-A PROTEASE ENZYME INHIBITORS; MUSCLE DISORDERS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-11-10 US disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed